Therapeutic Plasma Exchange Systems Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Therapeutic Plasma Exchange Systems Market is Segmented by Products, Indication (Neurological Disorders, Cardiovascular Disorders, Renal Disorders, Hematology Disorders, and Others), End-User, and Geography

Therapeutic Plasma Exchange Market Size

Therapeutic Plasma Exchange Systems Market

Compare market size and growth of Therapeutic Plasma Exchange Systems Market with other markets in Healthcare Industry

Therapeutic Plasma Exchange Market Analysis

The Therapeutic Plasma Exchange Systems Market is expected to register a CAGR of greater than 7.5% during the forecast period.

Therapeutic Plasma Exchange Industry Overview

The therapeutic plasma exchange systems market is moderately competitive and consists of several major players. Some of the companies are expanding their market position by adopting various strategies such as acquisitions and mergers, while others are developing new methods for the treatment and introducing new products to maintain their market share. For Instance, In April 2017, Terumo BCT received the first and only CE mark approval for its Spectra Optia Apheresis System to treat Guillain-Barre syndrome (GBS) and myasthenia gravis (MG) using Therapeutic Plasma Exchange in the European Market fueling the market revenue share. Few of the major players currently dominating the industry in terms of revenue are Asahi Kasei Corporation, Baxter International Inc, Terumo Corporation, B. Braun Melsungen AG, and Fresenius Kabi AG

Therapeutic Plasma Exchange Market Leaders

  1. Asahi Kasei Corporation

  2. Baxter International Inc

  3. Terumo Corporation

  4. B. Braun Melsungen AG

  5. Fresenius Kabi AG

  6. *Disclaimer: Major Players sorted in no particular order
Therapeutic Plasma Exchange Systems Market
Need More Details on Market Players and Competiters?
Download PDF

Therapeutic Plasma Exchange Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Global Prevalence of Autoimmune and Cardiac Diseases
    • 4.2.2 Growing R&D Activities and Clinical Trials to Increase the Application in Various Indications
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Treatment and Devices
    • 4.3.2 Lack of Skilled Healthcare Professionals in Emerging Markets
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Products
    • 5.1.1 Apheresis Machine
    • 5.1.2 Filters
    • 5.1.3 Others
  • 5.2 Indication
    • 5.2.1 Neurological Disorders
    • 5.2.2 Cardiovascular Disorders
    • 5.2.3 Hematology Disorders
    • 5.2.4 Renal Disorders
    • 5.2.5 Others
  • 5.3 End-User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United states
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Asahi Kasei Corporation
    • 6.1.2 Baxter International Inc
    • 6.1.3 B. Braun Melsungen AG
    • 6.1.4 Cerus Corporation
    • 6.1.5 Fresenius Kabi AG
    • 6.1.6 Haemonetics Corporation
    • 6.1.7 Hemacare Corporation
    • 6.1.8 IncMedica S.p.A.
    • 6.1.9 Kawasumi Laboratories
    • 6.1.10 Terumo Corporation
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Therapeutic Plasma Exchange Industry Segmentation

Therapeutic plasma exchange (TPE), also known as plasmapheresis is an extracorporeal blood purification technique that removes pathogenic substances such as pathogenic autoantibodies, immune complexes, cryoglobulins and cholesterol-containing lipoproteins from the plasma of patients and replaces with substitution fluid such as albumin solution, or often fresh frozen plasma. TPE is used in the treatment of various autoimmune diseases, renal disorders, hematology disorders, etc, which is likely to drive the growth of the market.

Products Apheresis Machine
Filters
Others
Indication Neurological Disorders
Cardiovascular Disorders
Hematology Disorders
Renal Disorders
Others
End-User Hospitals
Ambulatory Surgical Centers
Others
Geography North America United states
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Therapeutic Plasma Exchange Market Research FAQs

What is the current Therapeutic Plasma Exchange Systems Market size?

The Therapeutic Plasma Exchange Systems Market is projected to register a CAGR of greater than 7.5% during the forecast period (2025-2030)

Who are the key players in Therapeutic Plasma Exchange Systems Market?

Asahi Kasei Corporation, Baxter International Inc, Terumo Corporation, B. Braun Melsungen AG and Fresenius Kabi AG are the major companies operating in the Therapeutic Plasma Exchange Systems Market.

Which is the fastest growing region in Therapeutic Plasma Exchange Systems Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Therapeutic Plasma Exchange Systems Market?

In 2025, the North America accounts for the largest market share in Therapeutic Plasma Exchange Systems Market.

What years does this Therapeutic Plasma Exchange Systems Market cover?

The report covers the Therapeutic Plasma Exchange Systems Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Therapeutic Plasma Exchange Systems Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Therapeutic Plasma Exchange Systems Industry Report

Statistics for the 2025 Therapeutic Plasma Exchange Systems market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Therapeutic Plasma Exchange Systems analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Therapeutic Plasma Exchange Systems Report Snapshots

Therapeutic Plasma Exchange Systems Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)